Author/Authors :
Saleh, Rana Department of Pediatric Infectious Disease - Isfahan University of Medical Sciences - Isfahan, Iran , Rahimi, Hamid Department of Pediatric Infectious Disease - Isfahan University of Medical Sciences - Isfahan, Iran , Dehghan, Amin School of Medicine - Isfahan University of Medical Sciences - Isfahan, Iran , Sadeghizadeh, Atefeh Department of Pediatric Intensive Care - School of Medicine - Isfahan University of Medical Sciences - Isfahan, Iran , Gheisari, Alaleh Department of Pediatric Nephrology Disease - Isfahan University of Medical Sciences - Isfahan, Iran , Saeidi, Shima Department of Pediatric Infectious Disease - Isfahan University of Medical Sciences - Isfahan, Iran , Pourmoghaddas, Zahra Department of Pediatric Infectious Disease - Isfahan University of Medical Sciences - Isfahan, Iran
Abstract :
COVID‑19 outbreak has become a global health concern due to challenges in treatment and high mortality rate; therefore, its
therapeutic approaches play an important role in reducing the mortality rate and resolving this concern. Different therapies have
been introduced, including interferon beta‑1a and purification methods, for instance, plasmapheresis. In this article, we reported a
child with severe COVID‑19 who fully recovered after receiving plasmapheresis and interferon beta‑1a.
Keywords :
COVID‑19 , interferon beta‑1a , pediatric infectious disease , plasmapheresis